1076 related articles for article (PubMed ID: 24293218)
1. PPARγ-inactive Δ2-troglitazone independently triggers ER stress and apoptosis in breast cancer cells.
Colin-Cassin C; Yao X; Cerella C; Chbicheb S; Kuntz S; Mazerbourg S; Boisbrun M; Chapleur Y; Diederich M; Flament S; Grillier-Vuissoz I
Mol Carcinog; 2015 May; 54(5):393-404. PubMed ID: 24293218
[TBL] [Abstract][Full Text] [Related]
2. EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
Chbicheb S; Yao X; Rodeau JL; Salamone S; Boisbrun M; Thiel G; Spohn D; Grillier-Vuissoz I; Chapleur Y; Flament S; Mazerbourg S
Biochem Pharmacol; 2011 May; 81(9):1087-97. PubMed ID: 21338579
[TBL] [Abstract][Full Text] [Related]
3. Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling.
Park SK; Sanders BG; Kline K
Breast Cancer Res Treat; 2010 Nov; 124(2):361-75. PubMed ID: 20157774
[TBL] [Abstract][Full Text] [Related]
4. Δ2-Troglitazone promotes cytostatic rather than pro-apoptotic effects in breast cancer cells cultured in high serum conditions.
Berthe A; Flament S; Grandemange S; Zaffino M; Boisbrun M; Mazerbourg S
Cell Cycle; 2016 Dec; 15(24):3402-3412. PubMed ID: 27753533
[TBL] [Abstract][Full Text] [Related]
5. New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines.
Colin C; Salamone S; Grillier-Vuissoz I; Boisbrun M; Kuntz S; Lecomte J; Chapleur Y; Flament S
Breast Cancer Res Treat; 2010 Nov; 124(1):101-10. PubMed ID: 20054646
[TBL] [Abstract][Full Text] [Related]
6. Activation of the endoplasmic reticulum stress response by the amyloid-beta 1-40 peptide in brain endothelial cells.
Fonseca AC; Ferreiro E; Oliveira CR; Cardoso SM; Pereira CF
Biochim Biophys Acta; 2013 Dec; 1832(12):2191-203. PubMed ID: 23994613
[TBL] [Abstract][Full Text] [Related]
7. Endoplasmic reticulum stress mediates gamma-tocotrienol-induced apoptosis in mammary tumor cells.
Wali VB; Bachawal SV; Sylvester PW
Apoptosis; 2009 Nov; 14(11):1366-77. PubMed ID: 19771520
[TBL] [Abstract][Full Text] [Related]
8. Induction of endoplasmic reticulum stress response by TZD18, a novel dual ligand for peroxisome proliferator-activated receptor alpha/gamma, in human breast cancer cells.
Zang C; Liu H; Bertz J; Possinger K; Koeffler HP; Elstner E; Eucker J
Mol Cancer Ther; 2009 Aug; 8(8):2296-307. PubMed ID: 19671747
[TBL] [Abstract][Full Text] [Related]
9. Endoplasmic reticulum stress implicated in the development of renal fibrosis.
Chiang CK; Hsu SP; Wu CT; Huang JW; Cheng HT; Chang YW; Hung KY; Wu KD; Liu SH
Mol Med; 2011; 17(11-12):1295-305. PubMed ID: 21863214
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
Li M; Lee TW; Yim AP; Mok TS; Chen GG
J Cell Physiol; 2006 Nov; 209(2):428-38. PubMed ID: 16883598
[TBL] [Abstract][Full Text] [Related]
11. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
Li M; Lee TW; Mok TS; Warner TD; Yim AP; Chen GG
J Cell Biochem; 2005 Nov; 96(4):760-74. PubMed ID: 16149072
[TBL] [Abstract][Full Text] [Related]
12. Caspase-2 and JNK activated by saturated fatty acids are not involved in apoptosis induction but modulate ER stress in human pancreatic β-cells.
Němcová-Fürstová V; Balušíková K; Srámek J; James RF; Kovář J
Cell Physiol Biochem; 2013; 31(2-3):277-89. PubMed ID: 23466956
[TBL] [Abstract][Full Text] [Related]
13. The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells.
Yan KH; Yao CJ; Chang HY; Lai GM; Cheng AL; Chuang SE
Mol Carcinog; 2010 Mar; 49(3):235-46. PubMed ID: 19908241
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone attenuates epidermal growth factor receptor signaling independently of peroxisome proliferator-activated receptor in PC-3 cells.
Zhu H; Pan X; Qi H; Wang X; Hou S; Han B; Liu Z; Xu L
Oncol Rep; 2011 Jan; 25(1):81-90. PubMed ID: 21109961
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor γ ligand troglitazone and TRAIL synergistically induce apoptosis.
Koyama M; Sowa Y; Horinaka M; Goda AE; Fujiwara J; Sakai T
Oncol Rep; 2014 Feb; 31(2):947-54. PubMed ID: 24276615
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of the induction of endoplasmic reticulum stress by the anti-cancer agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT): Activation of PERK/eIF2α, IRE1α, ATF6 and calmodulin kinase.
Merlot AM; Shafie NH; Yu Y; Richardson V; Jansson PJ; Sahni S; Lane DJR; Kovacevic Z; Kalinowski DS; Richardson DR
Biochem Pharmacol; 2016 Jun; 109():27-47. PubMed ID: 27059255
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells.
Rashid-Kolvear F; Taboski MA; Nguyen J; Wang DY; Harrington LA; Done SJ
BMC Cancer; 2010 Jul; 10():390. PubMed ID: 20650001
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress.
Gardner OS; Shiau CW; Chen CS; Graves LM
J Biol Chem; 2005 Mar; 280(11):10109-18. PubMed ID: 15649892
[TBL] [Abstract][Full Text] [Related]
19. Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated receptor gamma ligand.
Nonaka M; Tazuma S; Hyogo H; Kanno K; Chayama K
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e198-206. PubMed ID: 17868335
[TBL] [Abstract][Full Text] [Related]
20. Prodigiosin activates endoplasmic reticulum stress cell death pathway in human breast carcinoma cell lines.
Pan MY; Shen YC; Lu CH; Yang SY; Ho TF; Peng YT; Chang CC
Toxicol Appl Pharmacol; 2012 Dec; 265(3):325-34. PubMed ID: 22982536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
